MEDIA RELEASE PR37147
Mainstay of the Global Workforce - 40-65 Year Olds - Hit Hardest by Chronic Obstructive Pulmonary
Disease (COPD)
LONDON, Nov.18 / PRNewswire-AsiaNet/ --
- New Report Highlights Global Economic Burden of the Disease
- An Estimated Two Billion Work Hours Lost Each Week
COPD Uncovered, a new report issued today reveals for the first time that people between the ages of 40 to
65 are emerging as the new face of this disease. Authored by Education for Health and other leading experts,
the report uncovers a new, younger majority of COPD patients(1) who are in the prime of their career, and
financially responsible for the care of their children and aging parents. The authors call for policymakers to
read the report and challenge their thinking on how COPD should be addressed in this critical age group who
are highly depended upon by society as leading wage earners(2,3).
COPD affects 210 million people and is predicted to be the third leading cause of death globally in ten years
time(4). A severely debilitating disease, COPD dramatically impairs the productivity of this population. In
fact, the report found that peoplee between 40 and 65 with COPD miss as many as ten hours of work per
week because of their condition(5). On a global scale, that represents more than two billion working hours lost
each week worldwide. Additionally, COPD causes nearly 28,000 years of lost productivity annually(6). The
report deduces that if left unchecked, COPD could have significant global workforce and economic
implications on patients, families, employers and society as the disease escalates.
"Given the potential economic impact, it is critical that 40 to 65 year olds with COPD are able to lead an
active and productive life," said Monica Fletcher, Chief Executive of Education for Health. "In releasing this
report we want to spark an important global dialogue with key global stakeholders on how best to invest in
earlier diagnosis and the management of these younger patients."
Other key insights from the report include:
- COPD costs more than asthma and diabetes - The cost of COPD
exceeds that of many other serious, long-term conditions including
asthma and diabetes(7). The worldwide burden of COPD is nearly double
that of diabetes and it causes more deaths(6).
- Effective COPD treatment must look beyond smoking cessation - It is
true that the primary cause of COPD is cigarette smoke(8) and smoking
cessation is an important part of COPD management. Yet many former
smokers develop symptoms and are diagnosed a decade or two after they
stopped. In fact, even if all smoking stopped today, the effect on COPD
statistics would not be seen for up to 20 years(9).
- COPD puts pressuse on healthcare systems - One in six
European and U.S. patients had visited the ER or hospital in a six
month period 2006-20075. Extrapolating these figures indicates that up
to 64 million COPD patients globally may be admitted to hospital due to
their condition each year. Additionally, a large majority of COPD
patients suffer from co-morbidities, such as heart disease, high blood
pressure and diabetes(10-13). In fact, 40 percent suffer from heart
disease10 and as many as 42 percent from high blood pressure(12,13).
- Families may also face burden - More women than men are now being
be diagnosed with COPD(14) - a patient segment central to family care.
About COPD
Chronic obstructive pulmonary disease (COPD) is a debilitating, life-threatening and progressive lung
disease that interferes with normal breathing(8). It is thought to cause around three million deaths per year -
on average one person every 10 seconds(4). COPD refers to emphysema and chronic bronchitis - two
commonly co-existing diseases of the lung. Due to lung deterioration, people with COPD experience
symptoms like chronic shortness of breath and cough that impact the ability to lead an active and productive
life(8). There is no cure for COPD but it can be treated.
About COPD Uncovered
COPD Uncovered represents the combined efforts of a multi-disciplinary committee of international experts,
coming together to bring forward some of the most burning issues in COPD today. Their aim is to highlight the
impact of COPD in an understudied and ignored patient segment between the ages of 40 and 65.
The COPD Uncovered initiative is a compendium of research and analysis undertaken by experts in
respiratory health. This initiative is sponsored by Novartis Pharma AG and is administered by a Secretariat
from Chandler Chicco Companies (CCC). The studies underlying the COPD Uncovered Report were
commissioned by Novartis Pharma AG.
Following the release of this report, the COPD Uncovered experts are conducting further quantitative
research into the direct and indirect costs of the disease among this age group. In 2010, they expect to
release the results of the study that will look at the specific impact of COPD on the daily lives of more than
2,000 COPD patients aged 45-67 from the U.S., the UK, Germany, Brazil, China and Turkey.
About the Authors
The COPD Uncovered Report, issued on World COPD Day 2009, is authored by the following individuals,
supported by Novartis with editorial assistance from medical education specialists from CCC:
- Monica Fletcher, Chief Executive, Education for Health and National
Respiratory Training Center, principle lead for COPD Uncovered
- Dr Marianella Salapatas, President, European Federation of Allergy and
Airways Diseases Patients' Associations
- Professor Thys van der Molen, Department of General Practice,
University of Groningen
- John Walsh, President and CEO, COPD Foundation
To download a copy of the COPD Uncovered report, visit:
For press enquiries, please contact:
Sue Davis Russell - PA to Chief Executive
Education for Health
Tel: +44-(0)1926-836841, Email: s.davisrussell@educationforhealth.org
Candy Perry - Head of Corporate Communications and External Affairs
Education for Health
Tel: +44-(0)1926-836995, Email: c.perry@educationforhealth.org
References:
SOURCE: Education for Health
NEWS 
